Blake Borgeson and Chris Gibson - Co-Founders of Recursion Pharmaceuticals
AI and computer vision for drug discovery.
Timeline
2013
- Founded
2017
- Partnered
April 2021 - IPO (RXRX)
Bloomberg, Recursion Pharmaceuticals Expands IPO to Raise $436 Million
MedCityNews, With new $600M fund, CRV expands into bioengineering investment, adds strategic growth stage deals
TechCrunch, Drug discovery startup Recursion raises $60 million in Series B from Data Collective
Zoba
Enterprise